Valuation : Medpace Holdings, Inc.

Market Cap 17.07B 14.65B 13.72B 12.56B 23.66B 1,630B 23.73B 162B 63.5B 822B 64.09B 62.7B 2,719B P/E 2026 *
34.8x
P/E 2027 * 31.9x
Enterprise Value 16.27B 13.96B 13.07B 11.97B 22.55B 1,554B 22.62B 155B 60.52B 783B 61.08B 59.76B 2,592B EV / Sales 2026 *
5.7x
EV / Sales 2027 * 5.23x
Free-Float
80.26%
Yield 2026 *
-
Yield 2027 * -
1 day-1.21%
1 week-0.17%
Current month+5.97%
1 month+3.77%
3 months+42.89%
6 months+35.37%
Current year+8.89%
1 week 605.63
Extreme 605.63
625.44
1 month 563.45
Extreme 563.45
629.69
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap.
24/08/26 Sell

Chief Executive Officer

-1,983 0.0071%
20/08/26 Fiscal year

Chief Financial Officer

10,200 0.0365%
20/08/26 Sell

Chief Executive Officer

-27,174 0.0974%
Change 5-day change 1-year change 3-year change Capi.($)
-1.21%-0.17%+29.16%+135.38% 17.07B
+0.10%+0.44%+2.80%+24.32% 51.14B
+2.65%+4.45%+481.36%+567.32% 47.4B
+0.33%+2.47%+38.97%+19.80% 43.19B
-0.88%+0.90%+24.11%+87.74% 42.35B
-2.27%-3.02%+14.22%+51.50% 33.23B
-0.36%-2.14% - - 16.38B
+0.25%+0.25%+12.03%+30.68% 14.76B
+0.44%+1.70%+82.07%+47.92% 14.15B
+0.47%-2.61%-2.46%-33.79% 13.09B
Average -0.05%+0.30%+75.81%+103.43% 29.28B
Weighted average by Cap. +0.07%+0.88%+101.09%+135.38%

Financials

2026 *2027 *
Net sales 2.85B 2.45B 2.29B 2.1B 3.95B 272B 3.96B 27.14B 10.61B 137B 10.71B 10.48B 454B 3.03B 2.6B 2.43B 2.23B 4.2B 289B 4.21B 28.81B 11.26B 146B 11.36B 11.12B 482B
Net income 503M 431M 404M 370M 697M 48B 699M 4.78B 1.87B 24.19B 1.89B 1.85B 80.06B 547M 469M 439M 402M 758M 52.2B 760M 5.2B 2.03B 26.31B 2.05B 2.01B 87.08B
Net Debt -802M -689M -645M -590M -1.11B -76.62B -1.12B -7.63B -2.98B -38.62B -3.01B -2.95B -128B -1.25B -1.07B -1.01B -921M -1.74B -120B -1.74B -11.92B -4.66B -60.27B -4.7B -4.6B -199B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
27/08/26 $611.57 -1.21% 198,155
26/08/26 $619.05 +0.81% 149,419
25/08/26 $614.06 -0.96% 247,113
24/08/26 $620.03 -0.12% 186,216
21/08/26 $620.75 +1.32% 225,882
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
611.57USD
Average target price
581.83USD
Spread / Average Target
-4.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock